ResVerlogix Corp. (“Resverlogix”) (TSX: RVX), an emerging international leader in cardiovascular research, announced today that it will host a live webcast on Monday July 31, 2006 at 10:00 am MDT. The webcast will allow securities analysts, shareholders, media and other key stakeholders the opportunity to hear from Dr. Jan Johansson, Sr. Vice-President Clinical Affairs and Donald McCaffrey, President & CEO discuss the Company’s strategic direction of its scientific and corporate programs.
